-
Mashup Score: 0Niraparib Treatment in Patients With Advanced Ovarian Cancer - 3 month(s) ago
Rafael G. Amado, M.D., President, Head of Global Oncology Research and Development, leading and overseeing the company’s global oncology research and development activities. In a pivotal Phase 3 randomized clinical trial, niraparib maintenance therapy has demonstrated remarkable efficacy for patients recently diagnosed with advanced ovarian cancer following initial platinum-based chemotherapy. This trial, involving 384 participants,
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
#Niraparib 🌟 In an interview with Rafael Amado MD, we dive into Phase 3 trial results showing a 55% extension in progression-free survival vs. placebo.[video]https://t.co/jfVWSiHAJm ➡️ #OvarianCancer @OncoAlert https://t.co/HyBJLbuZT0